NEW YORK BLOOD CENTER ENTERPRISES APPOINTS MEGHAN DELANEY, DO, MPH, AS NEXT PRESIDENT & CHIEF EXECUTIVE OFFICER

Current President and CEO Christopher D. Hillyer, MD, to serve as Special Advisor to the Board of Trustees

NEW YORK, Oct. 12, 2026 /PRNewswire/ -- The Board of Trustees of New York Blood Center Enterprises (NYBCe) has appointed Meghan Delaney, DO, MPH, as the organization's next President and Chief Executive Officer following an extensive national search. Dr. Delaney will assume the role on January 4, 2027, succeeding Christopher D. Hillyer, MD, who has led the organization since 2009.